A quick look at recorded outputs — details below.
- Articles 113
- Projects 0
- Books 0
- Proceedings 0
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
21
Q2
51
Q3
16
Q4
21
WoS (JCR)
Q1
18
Q2
14
Q3
43
Q4
23
TR Index
34
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
2
Top 10% articles
18
Avg percentile
52.6%
Top 1% share
1.9%
Top 10% share
16.8%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2026 Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy. YÖKSİS OpenAlex top 10% OpenAlex 90.7%
- 2026 Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis. YÖKSİS SJR Q2 JCR Q1 OpenAlex 43.4%
- 2026 Impact of crush syndrome severity on clinical outcomes after the earthquakes in southeastern Türkiye YÖKSİS SJR Q1 JCR Q2 OpenAlex 8.7%
- 2026 Iptacopan in IgA Nephropathy — Final 24-Month Data YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%
- 2025 The role of complement C3 deposition in ANCA-associated glomerulonephritis: a registry-based study of clinical, histopathological, and prognostic insights YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 90.8%
- 2025 Sklerodermal renal kriz sistemik sklerozun ilk bulgusu olabilir mi? YÖKSİS SJR Q2 JCR Q3 OpenAlex 32.8%
- 2025 Effect of Crush Syndrome Severity on Clinical Outcomes and Complications After the Earthquakes in Southeastern Türkiye YÖKSİS
- 2024 Biopsy-proven BK virus nephropathy in renal transplant recipients: A multi-central study from Turkey (BK-TURK STUDY) YÖKSİS SJR Q3 JCR Q4 OpenAlex 14.3%
- 2024 Patients with crush syndrome and kidney disease: lessons learned from the earthquake in Kahramanmaraş, Türkiye YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.6%
- 2024 Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group YÖKSİS SJR Q1 JCR Q1 OpenAlex 62.5%
- 2024 Post-COVID-19 Outcomes of Patients with Primary Glomerular Diseases: A Nationwide Controlled Study YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 6.7%
- 2024 Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: a multicenter retrospective analysis YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.4%
- 2024 Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy? YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.9%
- 2024 Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 95.3%
- 2024 Incidental finding of diffuse Tc‑99m methylene diphosphonate uptake in lungs in a patient with renal insufficiency and lymphoma YÖKSİS SJR Q2 JCR Q4 OpenAlex 41.7%
- 2024 Analysis of Crush Syndrome Patients With and Without Acute Kidney Injury during the 2023 Kahramanmaraş Earthquake: Experience of a Tertiary Referral Center from Türkiye YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex top 10% OpenAlex 95.9%
- 2023 Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group YÖKSİS SJR Q2 JCR Q3 OpenAlex 41.2%
- 2023 CHARACTERISTICS AND SURVIVAL DATA OF PATIENTS WITH PRIMARY FOCAL SEGMENTAL SEGMENTAL GLOMERULOSCLEROSIS: TSN-GOLD MULTI-CENTER STUDY YÖKSİS SJR Q1 JCR Q1 OpenAlex 9.6%
- 2023 Post‑COVID‑19 outcomes of non‑dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study YÖKSİS SJR Q2 JCR Q3 OpenAlex 69.0%
- 2023 Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning. YÖKSİS SJR Q2 JCR Q2 OpenAlex 29.3%